Comment on Embattled drugmaker Valeant misses profit estimates, slashes guidance

Embattled drugmaker Valeant misses profit estimates, slashes guidance

adcelannotate = {"mobilepaywallcategory" : "MOBILE_PREM-BUSINESS","nativepaywallcategory" : "NATIVE_PREM-BUSINESS"};Valeant Pharmaceuticals fell short of profit expectations in the fourth quarter and slashed its guidance for the current quarter and the full year, citing lower sales across many of its businesses. Shares slumped 16.5 percent in premarket trading ahead of the opening bell Tuesday.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News